Jinping Fang

Dr. Jinping Fang

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Behavioural Neurology
Verified
Journal Article
Open access
JFJinping Fang
Jinping Fang
DMDetao Meng
Detao Meng
BFBoyan Fang
Boyan Fang
Background: Social determinants of health (SDoH) have not been comprehensively studied in relation to Parkinson′s disease (PD), although they are well known to be associated with other chronic diseases. Here we assessed the relationship of a multidimensional, comprehensive measure of SDoH with the prevalence of PD in US adults. Methods: Among 48,637 adults in the National Health and Nutrition Examination Survey (NHANES) between 2001 and 2020, we identified PD cases based on self‐reported antiparkinsonian medication use. We formed a weighted multidomain SDoH score from eight indicators that assessed economic security, education, healthcare access, and social environment. Both multivariable logistic regression and restricted cubic spline (RCS) were used to estimate odds ratios and dose–response relationships and were adjusted for demographic and lifestyle factors. Results: More intensive adverse SDoH burden was significantly associated with higher PD prevalence (fully adjusted OR 1.31, 95% CI 1.16–1.47 per unit increase), and RCS analysis showed no evidence of nonlinearity ( p for nonlinearity = 0.370). Unemployment (OR 4.15, 95% CI 2.70–6.40) and food insecurity (OR 1.96, 95% CI 1.39–2.76) were strongly associated with higher PD prevalence, whereas reported lack of health care access was associated with lower identified PD (OR 0.27, 95% CI 0.15–0. 49), pointing to likely ascertainment bias. When stratifying, we observed meaningful effect modification by age ( p < 0.001), with stronger effects in middle‐aged individuals (≤ 60 years: OR 1.35, 95% CI 1.13–1.61), compared with an attenuation in older individuals. Conclusion: Poor SDoH were independently associated with higher PD prevalence, particularly among adults aged 60 years and younger. Unemployment and food insecurity showed strong positive associations, whereas the inverse association with healthcare access likely reflects ascertainment bias. These findings are hypothesis‐generating and suggest that SDoH may be relevant to PD screening and epidemiologic research. Longitudinal studies are needed to clarify temporality and causality.

Verified
Journal Article
Open access
PDF file
JFJinping Fang
Jinping Fang
WZWang Zhan
Wang Zhan
TFTao Feng
Tao Feng
YJYing Jiang
Ying Jiang
Introduction: Adult-onset Alexander disease (AOAD) is a rare astrocytopathy linked to the glial fibrillary acidic protein (GFAP) gene, which is known for its clinical heterogeneity and common misdiagnosis. In adults, it may present with bulbar dysfunction, pyramidal signs, ataxia, dysautonomia, cognitive decline, or parkinsonism, which often mimics atypical parkinsonian syndromes like multiple system atrophy (MSA). The purpose of this case series was to define practical clinical, radiological, and genetic cues for suspecting AOAD in adults with atypical parkinsonism, autonomic dysfunction, or paroxysmal focal symptoms, particularly when genetic findings are inconclusive. Case Presentation: Four patients, aged 40 to 59 years, had progressive and varied neurological symptoms, like gait disturbance, lower limb weakness, dysarthria, dysphagia, autonomic dysfunction, parkinsonism, cognitive decline, and paroxysmal focal deficits. Initial diagnoses were parkinsonian syndrome, stroke, transient ischemic attack (TIA), and MSA. Diagnostic Assessment and Intervention: Brain magnetic resonance imaging (MRI) in all patients showed characteristic lower brainstem abnormalities, particularly atrophy of the medulla oblongata and upper cervical spinal cord, consistent with the “tadpole sign.” GFAP sequencing identified one likely pathogenic variant (p.Arg70Trp) and three variants of uncertain significance: p.Glu122_Arg124del, p.Met415Ile, and p.Glu195Val. Management was mainly symptomatic; one patient showed significant motor improvement after repetitive transcranial magnetic stimulation (rTMS). Conclusions: AOAD should be considered in adults with parkinsonism-plus syndromes or unexplained combinations of bulbar symptoms, pyramidal signs, autonomic dysfunction, and cognitive decline. Recognizing the tadpole sign on MRI may improve diagnostic accuracy, particularly when genetic results are inconclusive.

14 May 2026 in Brain and Behavior
Verified
Journal Article
Open access
JFJinping Fang
Jinping Fang
KCKeke Chen
Keke Chen
YLYonghong Liu
Yonghong Liu
RWRuidan Wang
Ruidan Wang
YWYixuan Wang
Yixuan Wang
BFBoyan Fang
Boyan Fang
Background: Apathy impacts mood and social functioning in patients with Parkinson's disease (PWP), and its effect on motor rehabilitation outcomes remains unexplored. Objective: This study evaluates whether the presence of apathy (apathy status) is associated with rehabilitation outcomes in PWP. Methods: We retrospectively analyzed records of 122 PWP (Hoehn–Yahr stage ≤ 3) who underwent a 2‐week multidisciplinary intensive rehabilitation treatment (MIRT) between April 2020 and July 2024, dividing them into Parkinson's disease with apathy (PDA+, score > 14) and without apathy (PDA−, score ≤ 14) based on Modified Apathy Evaluation Scale (MAES). The outcome measures included the Movement Disorder Society Unified Parkinson's Disease Rating Scale part III (MDS‐UPDRS III), the Modified Parkinson Activity Scale (M‐PAS), the Five Times Sit to Stand Test (FTSTS), the Timed Up and Go Test (TUG), and the 10‐Meter Walk Test (10MWT). We conducted group comparisons and employed multiple linear regression analyses, treating the MAES both as a dichotomous variable and as a continuous predictor. In these analyses, we adjusted for baseline measures of MDS‐UPDRS III, FTSTS, and TUG. Additionally, we performed sensitivity analyses using alternative cutoffs (MAES > 13 and > 15). Results: Following MIRT, the PDA– group ( n = 75) showed significant improvements in MDS‐UPDRS III, M‐PAS, FTSTS, and TUG ( p < 0.001, p  < 0.001, p = 0.011, and p < 0.001, respectively). In contrast, no such improvements were observed in the PDA+ group ( n = 47). The improvements in MDS‐UPDRS III, FTSTS, and TUG scores exhibited significant differences between the groups ( p = 0.018, p = 0.046, and p = 0.042, respectively). In multivariable linear regression with MAES as a continuous variable, higher MAES was independently associated with smaller ΔMDS‐UPDRS III ( β = 0.147, 95% CI 0.017–0.277, p = 0.027; R 2 = 0.145), after adjustment for baseline MDS‐UPDRS III, FTSTS, and TUG. Modeling MAES dichotomously (> 14 vs. ≤ 14) produced similar results ( β = 2.378, 95% CI 0.341–4.415, p = 0.023; R 2 = 0.148). Sensitivity analyses using cutoffs of > 13 and > 15 yielded qualitatively comparable findings. Conclusions: Baseline apathy severity was associated with attenuated motor improvement after MIRT in PWP; understanding its mechanisms is crucial for personalized rehabilitation and treatment effectiveness. Trial Registration: ClinicalTrials.gov identifier: ChiCTR2000033768, 2020/06/11